Lionco Pharmaceutical Group Co.,Ltd. (603669.SS) SHH

Currency In CNY

AD

Valuation

Market Cap3.21B
Enterprise Value3.37B
P/E Ratio-30.81
PEG Ratio0.37
Price/Sales Ratio10.66
Price/Book Ratio6.7
Enterprise/Revenue11.05
Enterprise/EBITDA-51.63

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0.33
Operating Margin-0.2
AD

Management Effectiveness

Return On Assets-0.12
Return On Equity-0.21

Income Statement

Revenue322.12M
Revenue/Share0.58
Gross Profit109.79M
EBITDA-94.53M
Net Income-193.24M
Diluted EPS-0.27

Balance Sheet

Total Cash165.09M
Total Cash/Share0.23
Total Debt321.32M
Total Debt/Equity0.5
Current Ratio1.22
Book Value Per Share0.92

Price History

52-Week Change5.16
52-Week High8.4
52-Week Low4.01
Moving Average 50 Days6.01
Moving Average 200 Days5.17

Statistics

Average Volume31.8M
Shares Outstanding712.36M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0
Last Split Factor7:5
Last Split DateMay 26, 2020
AD